About us
Eurofins CALIXAR is a cutting-edge biotechnology company at the forefront of innovative solutions in the field of protein research for drug discovery. Established in 2011, with a vision to revolutionize the way we understand and interact with proteins, Eurofins CALIXAR has become a prominent name in the life sciences industry. The company joined the Eurofins Discovery group in April 2023. With a team of dedicated and talented scientists, Eurofins CALIXAR specializes in the production, solubilization, stabilization, and characterization of challenging recombinant active proteins, which play a crucial role in various biological processes and are prime targets for drug development. Moreover, we offer you a wide range of ready-to-use proteins including kinases, phosphatases, membrane proteins, ubiquitins, or epigenetic proteins to assist you in your work in the research and development of new drugs.
Trusted products to expedite your discovery & development – advance confidently
The company's unique technology and proprietary methodologies have enabled breakthroughs in membrane protein research, paving the way for the development of new therapeutics and vaccines. Eurofins CALIXAR is committed to scientific excellence and collaboration with pharmaceutical and biotech companies.
The company's unique technology and proprietary methodologies have enabled breakthroughs in membrane protein research, paving the way for the development of new therapeutics and vaccines. Eurofins CALIXAR’s commitment to scientific excellence and collaboration with pharmaceutical and biotech companies has resulted in significant advancements in areas such as neurodegenerative diseases, infectious diseases, and cancer. Their work not only contributes to the advancement of scientific knowledge but also has the potential to improve the lives of millions through the discovery of new treatments and therapies.
Eurofins CALIXAR’s dedication to pushing the boundaries of science, coupled with their passion for addressing some of the most challenging problems in the field, sets them apart as a leader in membrane protein research. As they continue to make strides in drug discovery, Eurofins CALIXAR remains committed to their mission of enhancing our understanding of membrane proteins and accelerating the development of life-changing medicines.
